Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07131670) titled 'Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes' on Aug. 6.

Study Type: Observational

Primary Sponsor: Qian Chu

Condition: Lung Cancer Chemoradiotherapy Patient-Reported Outcomes (PRO)

Intervention: Other: Electronic Patient-Reported Outcome Monitoring

Recruitment Status: Recruiting

Date of First Enrollment: June 1, 2024

Target Sample Size: 100

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07131670

Published by HT Digital Content Services with permission from Health Daily Diges...